Q3 2025 Financial Results
Access all the information about Grifols' Q3 Financial Results.
Showing 243 search results
Grifols’ Biotest receives first regulatory approval for its fibrinogen concentrate
Grifols Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes
Grifols Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating
Grifols reports quarterly revenues of EUR 1,865 million and group profit of EUR 127 million
Grifols earns Platinum rating in EcoVadis sustainability assessment
Grifols expands U.S. diagnostic manufacturing with a new facility in San Diego
Publications
Links to our latest financial and sustainability reports and other recent publications.
Financial Report
Explore our last financial and earnings annual report.
Sustainability Report
Integrated and Sustainability Annual Report.
Position Paper
The differential value of plasma-derived medicinal products (PDMPs).
Press Kit
Explore our Press Kit to find key facts and figures on Grifols.
Media Contacts
If you're a journalist or media professional with a question, contact our media relations team.